TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
145 hedge funds and large institutions have $559M invested in Tvardi Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 44 increasing their positions, 29 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
145
Holders Change
+12
Holders Change %
+9.02%
% of All Funds
2.98%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
35
Increased
44
Reduced
29
Closed
23
Calls
$10.3M
Puts
$6.71M
Net Calls
+$3.56M
Net Calls Change
+$1.64M
Top Buyers
| 1 |
First Manhattan
New York
|
+$8.01M |
| 2 |
Nuveen Asset Management
Chicago,
Illinois
|
+$5.71M |
| 3 |
CG
Carmignac Gestion
Paris,
France
|
+$4.75M |
| 4 |
BlackRock
New York
|
+$4.67M |
| 5 |
C
Chescapmanager
Baltimore,
Maryland
|
+$3.06M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$7.83M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$7.44M |
| 3 |
RCP
Rho Capital Partners
New York
|
-$6.74M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$4.76M |
| 5 |
BCM
Burrage Capital Management
Boston,
Massachusetts
|
-$3.29M |
